Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

41 results about "1-Tetralone" patented technology

1-Tetralone is a bicyclic aromatic hydrocarbon and a ketone. In terms of its structure, it can also be regarded as benzo-fused cyclohexanone. It is a colorless oil with a faint odor. It is used as starting material for agricultural and pharmaceutical agents. The carbon skeleton of 1-tetralone is found in natural products such as Aristelegone A (4,7-dimethyl-6-methoxy-1-tetralone) from the family of Aristolochiaceae used in traditional Chinese medicine.

Polyamide-imide insulating varnish and preparation method thereof

The invention relates to a polyamide-imide insulating varnish. The polyamide-imide insulating varnish is characterized in that the varnish comprises the following components in parts by weight: 100-120 parts of polyamide-imide solution and 2-5 parts of sepiolite material, wherein the polyamide-imide solution mainly comprises the following components in parts by weight: 20-35 parts of polyamide-imide resin and 20-60 parts of organic solvent; the organic solvent is one or a combination of N-methylpyrrolidone, chlorobenzene, bromobenzene, dichlorobenzene, dibromobenzene, 1-tetralone, fenchone, phorone and isophorone; and the sepiolite material mainly comprises sepiolite. The polyamide-imide insulated enamel wire provided by the invention forms a homogeneous stable system, the surface friction coefficient is below 0.30, and each index meets the International Electrotechnical Commission (IEC) standard requirement; and the polyamide-imide insulating varnish is suitable to be used as the enamel wire insulating varnish for coating the surface of the copper wire.
Owner:GUANGDONG JINGDA REA SPECIAL ENAMELED WIRE CO LTD

Preparing method of N-[2-(7- anisyl-1- naphthyl) ethide] acetamide

InactiveCN101759591AMeet the requirements of medicinal valueComply with purityOrganic active ingredientsNervous disorderDehydrogenationAntidepressants drugs
The present invention relates to a preparing method of agomelatine (N-[2-(7- anisyl-1- naphthyl) ethide] acetamide) of melatonin antidepressant drugs of commercial production. Firstly, 7- anisyl-1-tetralone is used as raw material, and is prepared into 2-(1,2,3,4- tetrahydrochysene-1- oxhydryl-7- methoxynaphthalene-1-base) acetonitrile in a cyanophoric way; then, 2-(1,2- dihydro-1-oxhydryl-7- methoxynaphthalene-1-base) acetonitrile is generated in an aromatization dehydrogenation way, and (7-- anisyl-1- naphthyl) acetonitrile is generated in a backflow reaction dehydrogenation way; finally, the agomelatine (N-[2-(7- anisyl-1- naphthyl) ethide] acetamide) is generated by reducing and acetylizing in a one-kettle way. The present invention has the advantages of high product purity, friendly environment, convenient operation and low cost, and is suitable for the commercial production.
Owner:ZHEJIANG HUAHAI PHARMA CO LTD

Preparation method of velpatasvir intermediate

InactiveCN107629029AHigh yieldHigh purityOrganic chemistryAlkyl transferOrtho-Toluidine
The invention provides a preparation method of a velpatasvir intermediate. According to the preparation method, ortho-toluidine is taken as an initial raw material, amino acetylation protection, Friedel-Crafts acylation, deamination protection, diazotization, and bromination are adopted so as to obtain 3-bromomethyl-4-bromoacetophenone; and alkylation with 7-hydroxy-1-tetralone, intramolecular coupling, and bromination are adopted so as to obtain 9-bromo-3-(2-bromoacetyl)-10, 11-dihydro-5H-benzo[d]naphtho[2,3-b]pyran-8(9H)-one. The yield and the purity of the velpatasvir intermediate preparedvia the preparation method are high, cost is low, and large size production is convenient to realize.
Owner:安徽省诚联医药科技有限公司

Near-infrared fluorescent probe for rapid detection of ONOO- and preparation method and application of near-infrared fluorescent probe for rapid detection of ONOO-

The invention provides a near-infrared fluorescent probe for rapid detection of peroxynitrite ions (ONOO-) and a preparation method and application of the near-infrared fluorescent probe for rapid detection of ONOO-. The preparation method includes steps: (1) weighing a certain mass of 6-hydroxy-1-tetralone and 4-(diethylamino)salicylaldehyde, dissolving in mixed solution of glacial acetic acid and concentrated sulfuric acid, ultrasonically well mixing, stirring overnight at the room temperature, quickly adding a product into ethyl acetate after reaction is completed, gradually separating outa red precipitate, filtering, washing with diethyl ether for three times, and performing vacuum drying to obtain a solid; (2) adding the obtained solid, potassium carbonate and 4-(bromomethyl)benzeneboronic acid pinacol ester into DMF solution, performing reaction at 60-80 DEG C for 5 hours, adding mixed solution into ice water after reaction is finished, extracting with chloroform, performing spin drying through a rotary evaporator, and carrying out column chromatography separation and purification to obtain a target product. The obtained probe is high in solubility and dispersity in aqueoussolution and can be used for rapid detection of ONOO- and cell imaging.
Owner:SHANXI UNIV

Process for the synthesis of indanylamine or aminotetralin derivatives and novel intermediates

A process for preparing indanylamine and aminotetralin derivatives from indanone or tetralone oximes by acylating the oximes with an organic anhydride, followed by catalytic hydrogenation in the presence of an organic anhydride with subsequent hydrolysis is described. The process is commercially feasible providing indanylamine and aminotetralin derivatives in high yield that are useful as intermediates in the production of therapeutically active compounds. Also described are novel intermediates, 1-indanone O-acetyl oximes and 1-tetralone O-acetyl oximes.
Owner:TEVA PHARMA IND LTD

Method for removing sulfur dioxide, sulfur trioxide and hydrogen sulfide in tail gas of oil burning boiler

The invention relates to a method for removing sulfur dioxide, sulfur trioxide and hydrogen sulfide in tail gas of an oil burning boiler. The method comprises the steps of introducing a sufficient amount of desulfurizing agent into the tail gas of the oil burning boiler through a pipeline, carrying out reaction on sulfur dioxide, sulfur trioxide, hydrogen sulfide and the desulfurizing agent to obtain complex precipitates, and filtering for removing the complex precipitates. The desulfurizing agent comprises the following components by weight percent: 2-ethoxybenzaldehyde, 4-methoxybenzyl bromide, cyclohexanone, triethylamine, 3-buten-1-ol, 1-tetralone, tritolyl phosphate, 3-dimethylaminopropylamine, 2-methoxy-5-fluorouracil, isopropylamine, 1-boc-3-piperidone, ethyl oxalyl monochloride and ethyl alcohol absolute. According to the method, the complexing capability with target substances is strong, the complex precipitate formation speed is high, the removal rate can up to 99%, the cost is low, the using amount is small, and scaling cannot occur, so that the environment cannot be damaged.
Owner:叶澄

Preparation method of 7-hydroxy-1-tetralone

The invention relates to a preparation method of 7-hydroxy-1-tetralone with a structural formula I. 4-(4-methoxyphenyl)butyric acid with a structural formula II is used as a starting material, in the presence of Lewis acid, a one pot process is used for carrying out cyclization and a demethylating reaction, and 7-hydroxy-1-tetralone is obtained. The preparation method has simple operation, phosphorus-containing reagents are not used, and environmental friendliness of the reaction is improved; in addition, yield of 7-hydroxy-1-tetralone is high (higher than 85%), and purity is good (high than 99.9%). Accordingly the method is completely suitable for industrial production, and satisfies requirements on quality of intermediates in medical industry.
Owner:JIANGXI SYNERGY PHARMA

Pyrrolidinyl hydroxamic acid compounds and their production process

InactiveUS6110947ALittle or no agonist activityBiocideNervous disorderHydrogenHydroxamic acid
A compound of the formula: and it pharmaceutically acceptable salt, wherein A is hydrogen, hydroxy or OY, where Y is a hydroxy protecting group; Ar is phenyl optionally substituted with one or more substituents selected from halo, hydroxy, C1-C4 alkyl, C1-C4 alkoxy, CF3, C1-C4 alkyloxy, and carboxy-C1-C4 alkyloxy; X is phenyl, naphthyl, biphenyl, indanyl, benzofuranyl, benzothiopheny, 1-tetralone-6-yl, C1-C4 alkylenedioxy, pyridyl, furyl and thienyl, these groups optionally being substituted with up to three substituents selected from halo, C1-C4 alkyl, C1-C4 alkoxy, hydroxy, NO2, CF3 and SO2CH3; and R is hydrogen, C1-C4 alkyl or a hydroxy protecting group. These compounds and pharmaceutical compositions containing them are useful as analgesic, antiinflammatory, diuretic, anesthetic or neuroprotective agents, or an agent for stroke or treatment of functional bowel diseases such as abdominal pain, for the treatment of a mammalian subject, especially a human subject. Further, the present invention provides processes for producing the hydroxamic compounds of formula (I) and their intermediate compounds of formula (II).
Owner:PFIZER INC

Treating agent for removing sulfur dioxide, sulfur trioxide and hydrogen sulfide from tail gas of oil burning boiler

The invention relates to a treating agent for removing sulfur dioxide, sulfur trioxide and hydrogen sulfide from tail gas of an oil burning boiler. The treating agent is prepared by compounding following components: 2-ethoxy benzaldehyde, 4-methoxy benzyl bromide, cyclohexanone, N,N-diethylethanamine, 3-butene-1-alcohol, 1-tetralone, tricresyl phosphate, N,N-dimethyl trimethylene diamine, 2-methoxy-5-fluorouracil, isopropamide, N-butyloxycarboryl-3-piperidone, ethyl chlorooxoacetate, N,N-dimethyl methylamine, 2-bromine-4'-methylacetophenone, quinoline-2-formaldehyde, absolute ethyl alcohol, and the like. The treating agent is strong in complexing power with target matters, the speed of forming complex and sediment is high, the removal rate can reach 99%, the cost is low, the dosage is less, no scaling is formed and no damage is caused to the environment.
Owner:叶澄

Nanosphere-metal composite catalyst, preparation method thereof, application and preparation method of 5-hydroxyl-1-tetralone

The invention provides a nanosphere-metal composite catalyst. The nanosphere-metal composite catalyst is prepared from SiO2 nanospheres and Pd metal particles loaded on the surfaces of the SiO2 nanospheres. The nanosphere-metal composite catalyst provided by the invention has higher catalytic activity and selectivity and can catalyze hydrogenation reaction by high efficiency. The invention also provides a preparation method of the catalyst; the catalyst can be prepared by an impregnation method, the preparation method is simple, the operation is easy and the cost is low; the nanosphere-metal composite catalyst provided by the invention is utilized to catalyze hydrogenation reaction of 1,5-dihydroxynaphthalene, the reaction selectivity is high and the yield of 5-hydroxyl-1-tetralone is high.
Owner:HANGZHOU LUPU BIOTECH CO LTD

Method for synthesizing saprorthoquinone

The invention belongs to the field of chemical synthesis, and in particular relates to a method for synthesizing saprorthoquinone which is shown as a formula (I) and serves as a natural product with high antitumor activity. The method comprises the following steps of: performing carbonyl alpha-site methylation, selective isopropyl substitution of an aromatic ring and Grignard reaction on 7-methoxyl-1-tetralone serving as an initiative raw material to prepare a key intermediate, namely 1-(4-methyl-3-pentenyl)-2-methyl-6-isopropyl-7-methoxyl-3,4-dihydronaphthalene; and aromatizing with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ), demethylating with ethanethiol and oxidizing with 2-iodoxybenzoic acid (IBX) to prepare the saprorthoquinone.
Owner:CHINA PHARM UNIV

Preparation process of montelukast sodium and its intermediate product

The present invention discloses a montelukast sodium preparation technology and intermediates; 7-chloro-2-methylquinine and 3-bromobenzaldehyde are used as raw materials for condensation reaction to obtain a compound A2; by carbon-carbon coupling of the compound A2 and 1-tetralone in the presence of a catalyst, an intermediate compound A3 is obtained; an important intermediate compound A4 is obtained by bio-enzyme catalyzed asymmetric Baeyer-villiger reaction, a chiral center is highly selectively constructed, an important intermediate compound A5 is prepared from the compound A4 by grignard reaction by use of methylmagnesium chloride, finally montelukast sodium (A6) is obtained; according to the technology, the highly chiral important intermediate compound A4 is obtained by bio-enzyme catalyzed asymmetric reaction, the catalyst can be effectively repeatedly used, and the kind of used solvents is less, and the montelukast sodium preparation technology has the characteristics of safety and environmental protection, greatly saves the production cycle, is low in production cost, high in total yield, and simple in operation of production units, and is suitable for industrialized production.
Owner:JIANGSU HANSYN PHARMA

Method for asymmetrically catalyzing and synthesizing (R)-4, 7-dimethyl-1-tetralone

The invention discloses a method for asymmetrically catalyzing and synthesizing (R)-4, 7-dimethyl-1-tetralone. According to the method, an asymmetrical Kumada cross coupling reaction is conducted on racemization 2-halogenated propionate ester catalyzed by bis oxazoline / cobalt and a methyl phenyl grignard reagent, and (S)-P-toluene propionate ester 2 is firstly generated; then, (S)-P-toluene propionate ester 2 is reduced to (S)-P-toluene propyl alcohol 3 through diisobutylaluminium hydride (DIBAL-H), and then (R)-4-p-methylphenyl-1-amylene 5 is obtained through bromine generation and coupling with and vinyl grignard reagent; next, a hydroboration-oxidation reaction and a Dess-Martin oxidizing reaction are sequentially conducted, and (R)-4-p-methylphenyl valeraldehyde 6 is obtained; finally, oxidation is conducted through silver oxide, an intramolecular Fourier acyl reaction is conducted, and (R)-4,7-dimethyl-1-tetralone is obtained in a ring-closure synthesis mode. The synthesis route is simple and concise, 8 reactions are conducted in all, the total yield is 27%, and the optical purity of a product is 90%.
Owner:CHINA AGRI UNIV

Chlorine-resistant fiber cloth for swimsuits

ActiveCN106544854AChlorine resistant effectFibre typesDyeing processSulfonyl chlorideFiber
The invention discloses long-acting chlorine-resistant fiber cloth for swimsuits. The chlorine-resistant fiber cloth comprises, by weight, 115 parts of polyester fibers, 15 parts of nanometer titanium dioxide, 1 part of tetrakis hydroxymethyl phosphonium sulfate, 2 parts of 5- hydroxy -1-tetralone, 2 parts of 4-cyclohexanone carboxylate, 1.5 parts of 2',4'-acetylphosphoramidothioate acetanilide, 3 parts of sodium pentanesulfonate, 2 parts of 4-isopropyl benzene sulfonyl chloride, 5 parts of 5-amino-2-methyl benzene sulfonic acid, 5 parts of sulfosuccinate butanedioic acid dioctyl phthalate sodium salt, 1 part of softener and 1 part of antioxidants.
Owner:JINJIANG HONGXING FASHION WEAVING

Method for refining 4 ¿C (3,4 ¿C dichlorobenzene group) ¿C 1 ¿C tetralin ketone

This invention discloses a method for refining 4-(3,4-dichlorophenyl)-1-tetralone. The method comprises: adding 4-(3,4-dichlorophenyl)-1-tetralone and solvent at a ratio of 1:(3-4) into a three-necked flask with a stirrer, heating under stirring until 4-(3,4-dichlorophenyl)-1-tetralone is completely dissolved, heating to 60-100 deg.C, refluxing for 0.5-2 h, cooling the filtrate to -5-10 deg.C, filtering, recrystallizing to obtain refined 4-(3,4-dichlorophenyl)-1-tetralone, and drying at 40-80 deg.C to obtain dry 4-(3,4-dichlorophenyl)-1-tetralone. The method has such advantages as high purity, short time, high yield, and stable product quality.
Owner:DAQING PETROLEUM ADMINISTRATION +1

Synthesis method of levo-amino compound

The invention discloses a synthesis method of a levo-amino compound S-7-chloro-1,2,3,4-tetrahydronaphthalene-1-amine. The method includes the steps of: performing a reaction to a raw material, 7-chloro-1-tetralone, with hydroxylamine to generate oxime; performing hydrogenation reduction to the oxime to prepare racemized amine; performing a one-pot dynamic kinetic resolution reaction to the product amine with lipase, a racemization catalyst and an acyl group donor; and hydrolyzing a resolution reaction product to prepare the S-7-chloro-1,2,3,4-tetrahydronaphthalene-1-amine. The method has simple operations, high product yield, high optical purity of the resolution product, and the like.
Owner:王际菊

Preparation method of R-7-chloro-1-tetralinylamine

The invention discloses a preparation method of R-7-chloro-1-tetralinylamine. The method comprises the following steps: carrying out reduction ammonification reaction on the raw material 7-chloro-1-tetralone to obtain 7-chloro-1,2,3,4-tetrahydronaphthyl-1-amine, and carrying out dynamic kinetic resolution on the 7-chloro-1,2,3,4-tetrahydronaphthyl-1-amine by using the combination of lipase and a racemization catalyst to obtain the R-7-chloro-1,2,3,4-tetrahydronaphthyl-1-amine. The method is simple to operate, and has the characteristics of wide raw material sources, favorable product yield, high optical purity of the resolution product and the like.
Owner:王际菊

Method for separating and purifying 4,8-dht from pecan exocarp and application of 4,8-dht

The invention discloses a method for separating and purifying 4,8-DHT from pecan exocarp and an application of 4,8-DHT. The method comprises the following steps: performing ultrasonic extraction to obtain a pecan exocarp extracting liquid by virtue of independent excitation type ultrasonic sounding, performing reduced pressure concentration, then passing through X-5 macroporous resin, performing gradient elution by using a mixed solution of water and ethanol, collecting an eluate obtained by eluting with a mixed liquid of water and ethanol in a volume ratio of 4 to 6, performing reduced pressure concentration to obtain a concentrated solution, performing silica-gel column chromatography, performing gradient elution by using a mixed solvent of petroleum ether and ethyl acetate, totally collecting 36 bottles of flow components by collecting a bottle of the flow components per 1 / 2 column volume, combining the tenth to eighteenth bottles of the flow components, performing reduced pressure concentration, and performing ethyl acetate crystallization to obtain a 4,8-dyhydroxy-1-tetralone crystalline compound. 4,8-DHT disclosed by the invention is of a 1:1 raceme, is less in impurity, has the purity of 99.5-99.8%, and ensures that the extraction rate reaches more than 94%; and the 4,8-DHT raceme has the effects on inhibiting seed germination and seedling growth of plants.
Owner:NINGBO INST OF TECH ZHEJIANG UNIV ZHEJIANG

Synthesis and resolution of 6-methoxy-1-aminotetralin

The invention discloses a method for preparing racemic 6-methoxy-1-aminotetralin and R-6-methoxy-1-aminotetralin with 6-methoxy-1-tetralone as the raw material. The method specifically includes the steps that 6-methoxy-1-tetralone is subjected to a reductive ammoniation reaction to obtain racemic 6-methoxy-1-aminotetralin, and racemic 6-methoxy-1-aminotetralin is subjected to dynamic kinetic resolution to obtain R-6-methoxy-1-aminotetralin. The method has the advantages that operation is easy, the product yield is high, and the optical purity is high. The method has great guidance and application value in the synthesis and resolution process of 6-methoxy-1-aminotetralin.
Owner:王际宽

Preparation method of 3,4-cyclopentyl-1-tetralone

The invention discloses a preparation method of 3,4-cyclopentyl-1-tetralone; under a condition of the presence of a copper catalyst, a nitrogen ligand, a reducing agent and an alkali, alkenyl benzaldehyde and an alpha-brominated unsaturated carbonyl compound are stirred in a solvent and subjected to a reaction for 12 hours at room temperature, and the 3,4-cyclopentyl-1-tetralone is obtained after postprocessing. The method is simple to operate, mild in condition, good in functional group compatibility, wide in substrate applicability, high in yield and good in selectivity, and only needs one-step operation.
Owner:ZHEJIANG NORMAL UNIVERSITY

Method for supercritical separation and purification of 4.8-DHT from pecan epicarp

The invention discloses a method for supercritical separation and purification of 4.8-DHT from pecan epicarp. The method comprises the following steps: extracting through a supercritical extraction kettle to obtain an extract; absorbing the extract by using methanol; carrying out silicagel column chromatography; carrying out gradient eluting by using a mixed solvent of petroleum ether and ethyl acetate; collecting a bottle of fluid per column volume, collecting 10 bottles of fluid in all; carrying out reduced-pressure concentration on the fourth bottle of fluid; and crystallizing by using ethyl acetate to obtain a 4,8-dyhydroxy-1-tetralone crystal compound. The 4,8-DHT is a 1:1 raceme and low in impurity content; the purity is 99.82%; the extraction rate is over 60%; and the 4.8-DHT raceme has the effects of inhibiting plant seed germination and seedling growth.
Owner:NINGBO INST OF TECH ZHEJIANG UNIV ZHEJIANG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products